Efficacy and Safety of Acupuncture in Managing COPD: An Overview of Systematic Reviews

IF 2.8 3区 医学 Q1 Medicine
Qian Zeng, Lu Liu, Ying Chen, Daohong Chen, Ziyang Zhou, Wenjiao Hu, Siyao Gong, Bin He, Wenchuan Qi, Chao Wang, Zuoqin Yang, Shuguang Yu, Ling Zhao
{"title":"Efficacy and Safety of Acupuncture in Managing COPD: An Overview of Systematic Reviews","authors":"Qian Zeng, Lu Liu, Ying Chen, Daohong Chen, Ziyang Zhou, Wenjiao Hu, Siyao Gong, Bin He, Wenchuan Qi, Chao Wang, Zuoqin Yang, Shuguang Yu, Ling Zhao","doi":"10.2147/copd.s464546","DOIUrl":null,"url":null,"abstract":"<strong>Background:</strong> Acupuncture has been used as an adjuvant therapy for Chronic obstructive pulmonary disease (COPD). However, systematic reviews (SRs) and meta-analyses (MAs) have reported inconsistent results and unknown quality. This overview aimed to summarize the current SRs/MAs to provide evidence for the effectiveness and safety of acupuncture in the treatment of COPD.<br/><strong>Methods:</strong> SRs/MAs were searched via eight databases from their establishment to December 31, 2023. The methodological quality was assessed by A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2). The risk of bias was assessed using the Risk of Bias in Systematic Review (ROBIS) tool. The Preferred Reporting Items for Systematic Reviews and Meta-analyses for Acupuncture (PRISMA-A) to evaluate the reporting quality. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to determine the strength of evidence. In addition, we also conducted an analysis of the acupuncture points used in the primary RCTs.<br/><strong>Results:</strong> Twenty-two SRs/MAs were included in this overview. Based on the assessment using AMSTAR 2, nineteen SRs/MAs were “critically low”. Eight SRs/MAs had a low risk of bias. Based on PRISMA-A, the reporting completeness of eighteen SRs/MAs were more than 70%. As for GRADE assessment, only three outcome measures were of high quality. COPD patients can benefit from moxibustion, acupoint application, acupoint catgut embedding, manual acupuncture, and electroacupuncture, as indicated by effectiveness in measures including lung function, 6MWD, mMRC, CAT, and acute exacerbation. In addition, the efficacy of TENS needed to be further demonstrated. The commonly used acupuncture points in the RCTs include BL13, BL23, and EX-B1.<br/><strong>Conclusion:</strong> Evidence from SRs showed that acupuncture is beneficial to lung function, acute exacerbation, 6MWD, mMRC and CAT. For SGRQ and brog scale, acupuncture should be used selectively, but this finding should still be taken with caution.<br/><br/>","PeriodicalId":13792,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/copd.s464546","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acupuncture has been used as an adjuvant therapy for Chronic obstructive pulmonary disease (COPD). However, systematic reviews (SRs) and meta-analyses (MAs) have reported inconsistent results and unknown quality. This overview aimed to summarize the current SRs/MAs to provide evidence for the effectiveness and safety of acupuncture in the treatment of COPD.
Methods: SRs/MAs were searched via eight databases from their establishment to December 31, 2023. The methodological quality was assessed by A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2). The risk of bias was assessed using the Risk of Bias in Systematic Review (ROBIS) tool. The Preferred Reporting Items for Systematic Reviews and Meta-analyses for Acupuncture (PRISMA-A) to evaluate the reporting quality. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to determine the strength of evidence. In addition, we also conducted an analysis of the acupuncture points used in the primary RCTs.
Results: Twenty-two SRs/MAs were included in this overview. Based on the assessment using AMSTAR 2, nineteen SRs/MAs were “critically low”. Eight SRs/MAs had a low risk of bias. Based on PRISMA-A, the reporting completeness of eighteen SRs/MAs were more than 70%. As for GRADE assessment, only three outcome measures were of high quality. COPD patients can benefit from moxibustion, acupoint application, acupoint catgut embedding, manual acupuncture, and electroacupuncture, as indicated by effectiveness in measures including lung function, 6MWD, mMRC, CAT, and acute exacerbation. In addition, the efficacy of TENS needed to be further demonstrated. The commonly used acupuncture points in the RCTs include BL13, BL23, and EX-B1.
Conclusion: Evidence from SRs showed that acupuncture is beneficial to lung function, acute exacerbation, 6MWD, mMRC and CAT. For SGRQ and brog scale, acupuncture should be used selectively, but this finding should still be taken with caution.

针灸治疗慢性阻塞性肺病的有效性和安全性:系统综述
背景:针灸已被用作慢性阻塞性肺病(COPD)的辅助疗法。然而,系统综述(SR)和荟萃分析(MA)报告的结果并不一致,且质量不明。本综述旨在总结目前的系统综述/荟萃分析,为针灸治疗慢性阻塞性肺病的有效性和安全性提供证据:方法:通过八个数据库检索了自建立至2023年12月31日的SR/MA。方法学质量采用系统综述评估工具 2 (AMSTAR 2) 进行评估。偏倚风险采用系统性综述偏倚风险(ROBIS)工具进行评估。采用《针灸系统综述和荟萃分析首选报告项目》(PRISMA-A)评估报告质量。采用 "建议评估、发展和评价分级法"(GRADE)确定证据的强度。此外,我们还对主要 RCT 中使用的穴位进行了分析:本综述共纳入了 22 项 SR/MA。根据 AMSTAR 2 的评估,19 项 SR/MA 为 "极低"。八份 SR/MA 的偏倚风险较低。根据 PRISMA-A,18 份 SR/MA 的报告完整性超过 70%。在 GRADE 评估中,只有三项结果指标的质量较高。从肺功能、6MWD、mMRC、CAT和急性加重等指标的有效性来看,艾灸、穴位贴敷、穴位埋线、手工针灸和电针可使慢性阻塞性肺病患者受益。此外,TENS 的疗效还有待进一步证实。RCT中常用的穴位包括BL13、BL23和EX-B1:来自SR的证据显示,针灸对肺功能、急性加重、6MWD、mMRC和CAT都有益处。对于 SGRQ 和 brog 量表,应选择性地使用针灸,但仍应谨慎对待这一发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.10
自引率
10.70%
发文量
372
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信